Company / Interest Expense per Share
ANI Pharmaceuticals, Inc. Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$1.54
FY2025
5-year range
$0.95 / $2.07
FY2021-FY2025
Trend
-25.4%
vs FY2024
Sector context
#8 of 43
Health Care
What the data says
ANI Pharmaceuticals, Inc.'s interest expense per share of $1.54 is higher than 81% of companies in the Health Care sector (FY2025). Interest Expense per Share has fluctuated over the past 10 years, ranging from $0.79 in FY2020 to $2.07 in FY2024.
Based on SEC 10-K filings.
1.54 in FY2025 with a 5-year CAGR of +14.3%. Top quartile in the Health Care sector.
Improved from $1.96 to $1.54 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -4.2%
- 5-Year CAGR
- +14.3%
- 10-Year CAGR
- -
Sector benchmark
-91.7% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share decreased 25.4% year-over-year.
- Ranks #8 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2024.
- Lowest interest expense per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.54 | -25.4% |
| FY2024 | $2.07 | +5.6% |
| FY2023 | $1.96 | +11.7% |
| FY2022 | $1.75 | +84.9% |
| FY2021 | $0.95 | +19.7% |
| FY2020 | $0.79 | -32.1% |
| FY2019 | $1.17 | -7.9% |
| FY2018 | $1.27 | +29.3% |
| FY2017 | $0.98 | +0.4% |
| FY2016 | $0.98 | -99.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026